Low molecular weight heparin (LMWH) therapy guided by low placental growth factor (PlGF) in a diabetes-prevalent population: preliminary retrospective cohort

Key Points

• Improved glycemic control was observed with LMWH therapy in low PlGF pregnancies, which often have diabetes-related complications.
• Findings show that lower incidences of small for gestational age (SGA) births are linked to LMWH treatment in affected populations.
• The analysis highlights a significant relationship between placental function and the use of LMWH therapy in this context.
• Further studies are warranted to explore biomarker-guided treatments for better pregnancy outcomes in similar populations.